The global AI in the healthcare market is projected to hit US$146.3 billion by 2031, growing at a compound annual growth rate of 39{7729880385ace00763d744956af66a2dd6156639dea227c3bc209fe61f7ca481}, according to a newly published report from Wissen Research. The surge is tied directly to exploding volumes of healthcare-related data, along with rising demand for precision medicine and pressure on providers to improve both clinical and operational efficiency.
Software takes the lead in 2025
In 2025, software solutions dominated the market. The report points to the rapid deployment of generative AI tools, flexible cloud-based delivery models, and shorter implementation cycles as the main reasons. Hospitals and health systems are increasingly turning to AI software for clinical decision support, ambient documentation, workflow automation, and medical coding.
Related: New Zealand oncology unit cuts travel time for Northland patients
Hardware and services still matter.
But the software segment pulled ahead because it offers much faster returns and easier integration — especially for organizations that already have some digital infrastructure in place.
Related: Understanding the Basics of Healthy Life: A Comprehensive Guide
Barriers that could slow things down
Data privacy and data protection remain very significant roadblocks. The report also flags high implementation costs and regulatory hurdles as serious obstacles. Validating AI algorithms for clinical use takes time and money, and not every hospital has the budget or expertise to do it. Some analysts caution that these issues could temper the pace of adoption, even if the long-term growth projection looks aggressive.
The industry is still working out exactly how to prove AI tools are safe and effective in real-world settings, and that process doesn’t happen overnight.
Related: FDA Cracks Down on Hidden Clinical Trial Data: What You Need to Know
North America leads, Asia Pacific accelerates
North America holds the largest share of the market right now. That growth is driven by advanced healthcare infrastructure, high digital health uptake, substantial AI investments, and supportive regulatory policies. The region also benefits from a concentration of large tech companies and research hospitals that can afford to experiment.
But the fastest growth is expected in the Asia Pacific region. Countries like China, India, and Japan are expanding healthcare digitization rapidly. Government investments in AI are rising, patient populations are large, and telehealth adoption is climbing — all factors that create demand for AI-driven tools in everything from diagnostics to administrative workflows.